News Gilead's new blockbuster HIV combination nears filing Pharma looks to file bictegravir and F/TAF later this year.
News Call for inquiry into NHS contaminated blood scandal Former health secretary says scandal was "criminal" cover-up.
News AbbVie takes aim at Gilead and BMS with 8-week hep C treatme... Trial backs patient-friendly regime in tough to treat strain.
News NHS funding crisis affecting community services - report Financial pressures on the health service are affecting community services, such as testing for sexually transmitted diseases and district nursing, according to a new report by The King’s F
Gilead Gilead aims to challenge GSK's HIV drug Tivicay But GSK hit back with plans for two-drug regimen.
News Can Gilead find another Pharmasset in 2017? Company needs to make acquisition to grow, admits CEO.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.